首页> 美国卫生研究院文献>The Journal of Experimental Medicine >The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction
【2h】

The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction

机译:抗B7单克隆抗体和环孢菌素A的组合在原发性混合淋巴细胞反应期间诱导同种异体抗原无能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Interaction of CD28/CTLA-4 on T cells with B7 on antigen-presenting cells constitutes an important costimulatory signal for T cells and is responsible for cyclosporin A-resistant interleukin 2 (IL-2) gene expression and potentially also for prevention of anergy induction after T cell receptor triggering. In this paper, we demonstrate that addition of a monoclonal antibody to B7, which blocks B7-CD28/CTLA-4 interaction, and of cyclosporin A together, but not separately, to a primary mixed lymphocyte reaction of freshly isolated human T cells towards a human B cell line, induces nonresponsiveness of alloantigen- specific cytotoxic T lymphocyte precursors, whereas reactivity to a third party stimulator is intact. Nonresponsiveness could be reversed by culture in IL-2, indicating that anergy, and not clonal deletion, is responsible for this phenomenon. Our finding opens important perspectives for the development of new therapeutic strategies in transplantation.
机译:T细胞上的CD28 / CTLA-4与抗原呈递细胞上的B7的相互作用构成了T细胞的重要共刺激信号,并负责环孢菌素A耐药白介素2(IL-2)基因的表达,还可能用于预防无反应性诱导在T细胞受体触发后。在本文中,我们证明了向B7(可阻止B7-CD28 / CTLA-4相互作用)的单克隆抗体和环孢菌素A一起(但不是单独地)添加到新鲜分离的人T细胞对a的初次混合淋巴细胞反应中人B细胞系诱导同种异体抗原特异性细胞毒性T淋巴细胞前体无反应,而与第三方刺激物的反应性则完好无损。 IL-2中的培养可逆转无反应性,表明无反应而非克隆缺失是造成这种现象的原因。我们的发现为开发新的移植治疗策略打开了重要的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号